Astellas, biotech VCs to pump $14M into virtual drug developer

Venture firms have teamed up with drugmaker Astellas Pharma to advance a startup called Telsar Pharma. Astellas and the venture firms, Interwest Partners and Sutter Hill Ventures, plan to invest $14 m…
Read the full story: News